Impact of perinatal exposure to equol enantiomers on reproductive development in rodents

Reproductive Toxicology

Volumn 32, Issue 1, 2011, Pages 33-42

  Brown, Nadine M ^a   Lindley, Stephanie L ^a   Witte, David P ^a,b   Setchell, Kenneth D R ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Enantiomer; Equol; Reproduction; Rodent model; Toxicology

Indexed keywords

EQUOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH RATE; BIRTH WEIGHT; CONTROLLED STUDY; ENANTIOMER; EXPOSURE; FEMALE; FERTILITY; GENDER; GENITAL MALFORMATION; HISTOPATHOLOGY; MALE; NONHUMAN; PERINATAL EXPOSURE; RAT; REPRODUCTIVE TOXICITY; TESTIS DESCENT; UTERUS DISEASE; UTERUS HYPERPLASIA; VAGINA;

ADMINISTRATION, ORAL; ANAL CANAL; ANIMALS; FEMALE; FERTILITY; GENITALIA; ISOFLAVONES; MALE; MATERNAL EXPOSURE; MOLECULAR CONFORMATION; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SEX CHARACTERISTICS; SEXUAL MATURATION; STEREOISOMERISM;

RATTUS; RODENTIA;

EID: 79960443009     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.05.008     Document Type: Article

References (93)

1. Messina M., Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991, 83:541-546.
2. Messina M.J., Loprinzi C.L. Soy for breast cancer survivors: a critical review of the literature. J Nutr 2001, 131:3095S-3108S.
3. Setchell K.D.R., Brown N.M., Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132:3577-3584.
4. Setchell K.D.R., Clerici C. Equol: pharmacokinetics and biological actions. J Nutr 2010, 140:1363S-1368S.
5. Rowland I.R., Wiseman H., Sanders T.A., Adlercreutz H., Bowey E.A. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000, 36:27-32.
6. Lampe J.W., Karr S.C., Hutchins A.M., Slavin J.L. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998, 217:335-339.
7. Setchell K.D.R., Clerici C. Equol: history, chemistry, and formation. J Nutr 2010, 140:1355S-1362S.
8. Lampe J.W. Is equol the key to the efficacy of soy foods?. Am J Clin Nutr 2009, 89:1664S-1667S.
9. Setchell K.D., Borriello S.P., Hulme P., Kirk D.N., Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984, 40:569-578.
10. Setchell K.D.R., Cole S.J. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006, 136:2188-2193.
11. Lydeking-Olsen E., Beck-Jensen J.E., Setchell K.D., Holm-Jensen T. Soymilk or progesterone for prevention of bone loss-a 2 year randomized, placebo-controlled trial. Eur J Nutr 2004, 43:246-257.
12. Uesugi S., Watanabe S., Ishiwata N., Uehara M., Ouchi K. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. Biofactors 2004, 22:221-228.
13. Ishimi Y. Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice. J Nutr 2010, 140:1373S-1376S.
14. Wu J.Q., Guo C.J., Gu J.F. Progress in research of equol: a metabolite of the isoflavone daidzein. Sheng Li Ke Xue Jin Zhan 2006, 37:359-361.
15. WuJ, Oka J., Ezaki J., Ohtomo T., Ueno T., Uchiyama S., et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 2007, 14:866-874.
16. Fuhrman B.J., Teter B.E., Barba M., Byrne C., Cavalleri A., Grant B.J., et al. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17:33-42.
17. Jou H.-J., Wu S.-C., Chang F.-W., Ling P.-Y., Chu K.-S., Wu W.-H. Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. Int J Gynecol Obst 2008, 102:44-49.
18. Clerici C., Setchell K.D., Battezzati P.M., Pirro M., Giuliano V., Asciutti S., et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 2007, 137:2270-2278.
19. Tormala R., Appt S., Clarkson T.B., Groop P.H., Ronnback M., Ylikorkala O., et al. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation. Atherosclerosis 2008, 198:174-178.
20. Akaza H., Miyanaga N., Takashima N., Naito S., Hirao Y., Tsukamoto T., et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 2004, 34:86-89.
21. Ozasa K., Nakao M., Watanabe Y., Hayashi K., Miki T., Mikami K., et al. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 2004, 95:65-71.
22. Jackson M.D., McFarlane-Anderson N.D., Simon G.A., Bennett F.I., Walker S.P. Urinary phytoestrogens and risk of prostate cancer in Jamaican men. Cancer Causes Control 2010, 21:2249-2257.
23. Lund T.D., Munson D.J., Haldy M.E., Setchell K.D., Lephart E.D., Handa R.J. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 2004, 70:1188-1195.
24. Niculescu M.D., Pop E.A., Fischer L.M., Zeisel S.H. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem 2007, 18:380-390.
25. Coward L., Barnes N.C., Setchell K.D.R., Barnes S. Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993, 41:1961-1967.
26. Murphy P.A Phytoestrogen content of processed soybean products. Food Technol 1982, 43:60-64.
27. Kostelac D., Rechkemmer G., Briviba K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 2003, 51:7632-7635.
28. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M., Nohara T., et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001, 24:351-356.
29. Muthyala R.S., Ju Y.H., Sheng S., Williams L.D., Doerge D.R., Katzenellenbogen B.S., et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004, 12:1559-1567.
30. Setchell K.D.R., Clerici C., Lephart E.D., Cole S.J., Heenan C., Castellani D., et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005, 81:1072-1079.
31. Setchell KDR, Sirokin VI, In: Office UP, editors. Method for the enantioseleactive hydrogenation of chromenes. USA; 2005.
32. Brown N.M., Belles C.A., Lindley S.L., Zimmer-Nechemias L., Witte D.P., Kim M.O., et al. Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol. Food Chem Toxicol 2010, 48:3042-3050.
33. Brown N.M., Belles C.A., Lindley S., Zimmer-Nechemias L.D., Zhao X., Witte D.P., et al. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis 2010, 31:886-893.
34. Brown N.M., Setchell K.D. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest 2001, 81:735-747.
35. Degen G.H., Janning P., Diel P., Michna H., Bolt H.M. Transplacental transfer of the phytoestrogen daidzein in DA/Han rats. Arch Toxicol 2002, 76:23-29.
36. Doerge D.R., Churchwell M.I., Chang H.C., Newbold R.R., Delclos K.B. Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats. Reprod Toxicol 2001, 15:105-110.
37. Lamartiniere C.A., Wang J., Smith-Johnson M., Eltoum I.E., Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 2002, 65:228-238.
38. Bennetts H.W., Underwood E.J., Shier F. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust Vet J 1946, 22:2-12.
39. Ishiwata N., Melby M.K., Mizuno S., Watanabe S. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause 2009, 16:141-148.
40. Matulka R.A., Matsuura I., Uesugi T., Ueno T., Burdock G. Developmental and reproductive effects of SE5-OH: an equol-rich soy-based ingredient. J Toxicol 2009, 2009:307618.
41. Jackson R.L., Greiwe J.S., Desai P.B., Schwen R.J. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor beta-agonist being developed for the treatment of menopausal symptoms. Menopause 2011, 18:185-193.
42. Medlock K.L., Branham W.S., Sheehan D.M. Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc Soc Exp Biol Med 1995, 208:67-71.
43. Awoniyi C.A., Roberts D., Veeramachaneni D.N., Hurst B.S., Tucker K.E., Schlaff W.D. Reproductive sequelae in female rats after in utero and neonatal exposure to the phytoestrogen genistein. Fertil Steril 1998, 70:440-447.
44. Nagata C. Factors to consider in the association between soy isoflavone intake and breast cancer risk. J Epidemiol 2010, 20:83-89.
45. Schedin P., Mitrenga T., Kaeck M. Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 2000, 5:211-225.
46. Hsueh A.J., Billig H., Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994, 15:707-724.
47. Leblond C.P., Clermont Y. Definition of the stages of the cycle of the seminiferous epithelium in the rat. Ann N Y Acad Sci 1952, 55:548-573.
48. Leblond C.P., Clermont Y. Spermiogenesis of rat, mouse, hamster and guinea pig as revealed by the periodic acid-fuchsin sulfurous acid technique. Am J Anat 1952, 90:167-215.
49. Moore C., Hughes W., Gallagher T. Rat seminal vesicle cytology as a testis-hormone indicator and the prevention of castration changes by testis extract injection. Am J Anat 1930, 45:109-135.
50. Frey H.L., Peng S., Rajfer J. Synergy of abdominal pressure and androgens in testicular descent. Biol Reprod 1983, 29:1233-1239.
51. Ojeda S.R., Jameson H.E. Developmental patterns of plasma and pituitary growth hormone (GH) in the female rat. Endocrinology 1977, 100:881-889.
52. Reid B., Cleland K. The structure and function of the epididymis. Aust J Zool 1957, 5:223-252.
53. Boorman G.A., Eustis S.L., Elwell M.R., MacKenzie W.F., Montgomery C. Pathology of the fischer rat 1990, p. 1-556.
54. Yee S., Burdock G.A., Kurata Y., Enomoto Y., Narumi K., Hamada S., et al. Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae. Food Chem Toxicol 2008, 46:2713-2720.
55. Setchell K.D.R., Zhao X., Shoaf S.E., Ragland K. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J Nutr 2009, 139:2037-2043.
56. Medlock K.L., Branham W.S., Sheehan D.M. The effects of phytoestrogens on neonatal rat uterine growth and development. Proc Soc Exp Biol Med 1995, 208:307-313.
57. Messina M. The endometrial effects of isoflavones: a discussion paper. Complement Ther Clin Pract 2008, 14:212-214.
58. Setchell K.D.R. Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001, 20:354S-362S. (discussion 381S-383S).
59. Unfer V., Casini M.L., Costabile L., Mignosa M., Gerli S., Di Renzo G.C. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004, 82:145-148. (quiz 265).
60. Legette L.L., Martin B.R., Shahnazari M., Lee W.H., Helferich W.G., Qian J., et al. Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. J Nutr 2009, 139:1908-1913.
61. Rachon D., Vortherms T., Seidlova-Wuttke D., Menche A., Wuttke W. Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats. Climacteric 2007, 10:416-426.
62. Phrakonkham P., Chevalier J., Desmetz C., Pinnert M.F., Berges R., Jover E., et al. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats. Toxicol Appl Pharmacol 2007, 224:105-115.
63. Wood C.E., Appt S.E., Clarkson T.B., Franke A.A., Lees C.J., Doerge D.R., et al. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Reprod 2006, 75:477-486.
64. Schwen R., Jackson R., Proudlock R. Genotoxicity assessment of S-equol in bacterial mutation, chromosomal aberration, and rodent bone marrow micronucleus tests. Food Chem Toxicol 2010, 48:3481-3485.
65. Ferguson S.A., Delclos K.B., Newbold R.R., Flynn K.M. Few effects of multi-generational dietary exposure to genistein or nonylphenol on sodium solution intake in male and female Sprague-Dawley rats. Neurotoxicol Teratol 2009, 31:143-148.
66. Jefferson W.N., Padilla-Banks E., Goulding E.H., Lao S.P., Newbold R.R., Williams C.J. Neonatal exposure to genistein disrupts ability of female mouse reproductive tract to support preimplantation embryo development and implantation. Biol Reprod 2009, 80:425-431.
67. Newbold R.R., Banks E.P., Bullock B., Jefferson W.N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001, 61:4325-4328.
68. Setchell K.D.R., Zhao X., Jha P., Heibi J.E., Brown N.M. The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers. Am J Clin Nutr 2009, 90:1029-1037.
69. Adlercreutz H., Yamada T., Wahala K., Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol 1999, 180:737-743.
70. Foster W.G., Chan S., Platt L., Hughes C.L. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett 2002, 129:199-205.
71. Weber K.S., Setchell K.D., Lephart E.D. Maternal and perinatal brain aromatase: effects of dietary soy phytoestrogens. Brain Res Dev Brain Res 2001, 126:217-221.
72. McClain R.M., Wolz E., Davidovich A., Edwards J., Bausch J. Reproductive safety studies with genistein in rats. Food Chem Toxicol 2007, 45:1319-1332.
73. Messina M. Resolving the soy-breast cancer controversy. J Am Diet Assoc 2006, 106:363-364.
74. Messina M.J., Persky V., Setchell K.D., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994, 21:113-131.
75. Ju Y.H., Allred K.F., Allred C.D., Helferich W.G. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 2006, 27:1292-1299.
76. Guha N., Kwan M.L., Quesenberry C.P., Weltzien E.K., Castillo A.L., Caan B.J. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 2009, 118:395-405.
77. Shu X.O., Zheng Y., Cai H., Gu K., Chen Z., Zheng W., et al. Soy food intake and breast cancer survival. JAMA 2009, 302:2437-2443.
78. Ju Y.H., Fultz J., Allred K.F., Doerge D.R., Helferich W.G. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 2006, 27:856-863.
79. Setchell K.D.R., Gosselin S.J., Welsh M.B., Johnston J.O., Balistreri W.F., Kramer L.W., et al. Dietary estrogens-a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987, 93:225-233.
80. Nielsen T.S., Norgaard J.V., Purup S., Frette X.C., Bonefeld-Jorgensen E.C. Estrogenic activity of bovine milk high or low in equol using immature mouse uterotrophic responses and an estrogen receptor transactivation assay. Cancer Epidemiol 2009, 33:61-68.
81. Selvaraj V., Zakroczymski M.A., Naaz A., Mukai M., Ju Y.H., Doerge D.R., et al. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol Reprod 2004, 71:966-972.
82. Thigpen J.E., Setchell K.D.R., Padilla-Banks E., Haseman J.K., Saunders H.E., Caviness G.F. Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats. Environ Health Perspect 2007, 115:1717-1726.
83. Thigpen J.E., Haseman J.K., Saunders H.E., Setchell K.D.R., Grant M.G., Forsythe D.B. Dietary phytoestrogens accelerate the time of vaginal opening in immature CD-1 mice. Comp Med 2003, 53:607-615.
84. Messina M. Soybean isoflavone exposure does not have feminizing effects on men: a critical examination of the clinical evidence. Fertil Steril 2010, 93:2095-2104.
85. Huhtaniemi I. Molecular aspects of the ontogeny of the pituitary-gonadal axis. Reprod Fertil Dev 1995, 7:1025-1035.
86. Boorman G., Chapin R. Pathology of the fischer rat 1990, Academic Press, Inc., San Diego, CA.
87. Shutt D.A. The effects of plant oestrogens on animal reproduction. Endeavor 1976, 35:110-113.
88. Pope G.S. The importance of pasture plant oestrogens in the reproduction and lactation of grazing animals. Dairy Sci Abstr 1954, 16:334-355.
89. Wisniewski A.B., Klein S.L., Lakshmanan Y., Gearhart J.P. Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. J Urol 2003, 169:1582-1586.
90. Rachon D., Vortherms T., Seidlova-Wuttke D., Wuttke W. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause 2007, 14:925-932.
91. Lephart E.D., Porter J.P., Lund T.D., Bu L., Setchell K.D., Ramoz G. Dietary isoflavones alter regulatory behaviors, metabolic hormones and neuroendocrine function in Long-Evans male rats. Nutr Metab (Lond) 2004, 1:16.
92. Kishida T., Mizushige T., Ohtsu Y., Ishikawa S., Nagamoto M., Izumi T., et al. Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy. Obesity 2008, 16(Silver Spring):290-297.
93. Engel S.M., Levy B., Liu Z., Kaplan D., Wolff M.S. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol 2006, 21:110-112.